Alfasigma Denmark ApS
Private limited companyCVR 42447242København ØActive
Alfasigma Denmark ApS is a private limited company, based in København Ø, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2021. Net profit fell 38% from 2024 to 2025, ending at DKK 505k. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 12% (2024 → 2025), to DKK 10.7m.
- Net profit fell 38% (2024 → 2025), to DKK 505k.
- Equity rose 12% (2024 → 2025), to DKK 4.6m.
Employees
- 1 more employees than a year earlier: 6 (07/2026) against 5 (07/2025).
Management and owners, last 24 months
- New in management: Line de Linde Henriksen (director, 24/07/2025), Alberto Avaltroni (director, 24/07/2025) and Massimo Giorgio Visentin (director, 31/03/2026) (+1).
- Stepped down: Michele Manto (director, 31/03/2026), Marcel de Jong (director, 24/07/2025) and Maria Chiara Cucchi (director, 31/03/2026).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2025 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 5,081 | 13,809 | 11,778 | 9,532 | 10,681 | +12% |
| Operating profit (EBIT) | – | 1,892 | 1,776 | 1,294 | 845 | −34.7% |
| Profit before tax | 511 | 1,854 | 1,783 | 1,051 | 750 | −28.6% |
| Net profit | 398 | 1,446 | 1,390 | 815 | 505 | −38% |
| Total assets | 9,588 | 17,049 | 7,284 | 14,902 | 11,653 | −21.8% |
| Equity | 438 | 1,884 | 3,274 | 4,089 | 4,594 | +12.4% |
| Liabilities | 9,150 | 15,164 | 4,011 | 10,813 | 7,058 | −34.7% |
| Cash and cash equivalents | 3,604 | 0 | – | 834 | 0 | −100% |
| Average number of employees | 3 | 6 | 6 | 4 | 5 | +25% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
5 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 22/07/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 21/07/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 23/07/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 30/06/2023 | The company | PDFXBRL |
| 2021 | 03/06/2021 – 31/12/2021 | 05/07/2022 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 4,302of 69,742 Better than 94% | No. 14,965of 69,964 Better than 79% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 40of 150 Better than 74% | No. 66of 150 Better than 56% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 4,069of 33,588 Better than 88% | No. 6,454of 33,687 Better than 81% |
| All companies of type ApS66,508 companies in the comparison | No. 5,601of 66,379 Better than 92% | No. 11,944of 66,505 Better than 82% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Alfasigma Denmark ApSDKK 10.7m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Alfasigma Denmark ApSDKK 505k
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Alfasigma Denmark ApSDKK 4.6m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Alfasigma Denmark ApS6
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Alfasigma Spa100%
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Line de Linde Henriksen | Director | 24/07/2025 |
| Alberto Avaltroni | Director | 24/07/2025 |
| Massimo Giorgio Visentin | Director | 31/03/2026 |
| Alessio Battaglia | Director | 31/03/2026 |
- Founders
- Galapagos NV
Former management (5)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Bart Filius | Director | 03/06/2021 | 20/06/2023 |
| Michele Manto | Director | 03/06/2021 | 31/03/2026 |
| Marcel de Jong | Director | 03/06/2021 | 24/07/2025 |
| Samara Orsatti | Director | 31/01/2024 | 15/09/2024 |
| Maria Chiara Cucchi | Director | 15/09/2024 | 31/03/2026 |
Signing rule: Selskabet tegnes af en direktør eller af den samlede direktion.
Address and production units
1 active production unitsSundkrogsgade 21
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Remote Technology ApSBusiness and other management consultancy activities
- JD Sports Fashion Denmark ApSWholesale of clothing
- Csc (denmark) ApSBusiness and other management consultancy activities
- Edyn Aparthotel Denmark ApSHotels and similar accommodation
- Hotel Co 51 Denmark ApSHotels and similar accommodation
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Alfasigma Denmark ApS | Sundkrogsgade 21, 2100 København Ø | 6 | 1027238161 |
Purpose
Selskabets formål er at drive virksomhed inden for kommercialisering af farmaceutiske produkter samt aktiviteter, der efter direktionens skøn er forbundet hermed.
The purpose is quoted from the register in Danish.
Changes year by year
25 registered events20265 changesaccounts 1 · management 4
- AccountsAnnual report for 2025 published
- ManagementAlessio Battaglia appointed director
- ManagementMassimo Giorgio Visentin appointed director
- ManagementMaria Chiara Cucchi stepped down as director
- ManagementMichele Manto stepped down as director
20254 changesmanagement 3 · accounts 1
- ManagementLine de Linde Henriksen appointed director
- ManagementAlberto Avaltroni appointed director
- ManagementMarcel de Jong stepped down as director
- AccountsAnnual report for 2024 published
20248 changesaddress 1 · name 1 · management 3 · accounts 1 · ownership 2
- AddressMoved to Sundkrogsgade 21, 2100 København Ø
- NameName changed from Galapagos Biopharma Denmark ApS to Alfasigma Denmark ApS
- ManagementMaria Chiara Cucchi appointed director
- ManagementSamara Orsatti stepped down as director
- AccountsAnnual report for 2023 published
- ManagementSamara Orsatti appointed director
- OwnershipALFASIGMA SpA registered as owner (100%)
- OwnershipGalapagos NV is no longer registered as owner
20232 changesaccounts 1 · management 1
- AccountsAnnual report for 2022 published
- ManagementBart Filius stepped down as director
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20215 changesfounded 1 · management 3 · ownership 1
- FoundedRegistered as Galapagos Biopharma Denmark ApS
- ManagementBart Filius appointed director
- ManagementMarcel de Jong appointed director
- ManagementMichele Manto appointed director
- OwnershipGalapagos NV registered as owner (100%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.